Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

Dixon-Douglas JR, Drubay D, Salgado R, Acs B, van der Laak J, Yuan Y, Amgad M, Cooper L, Hagos Y, AbdulJabbar K, Meakin J, van Ginneken B, Yan H, Lemonnier J, Penault-Llorca F, Lacroix-Triki M, Joensuu H, Kellokumpu-Lehtinen PL, Loibl S, Denkert C, Viale G, Colleoni MA, Sotiriou C, Piccart M, Dieci MV, Demaria S, Kammler R, Wolff AC, Sparano JA, Adams S, Badve S, Gray RJ, Curigliano G, Salomon AV, Nielsen TO, Pusztai L, Ciompi F, Michiels S, Loi S, International Immuno-Oncology Biomarker Working Group

Open source

DOI
10.1016/s1470-2045(26)00339-6
Published
2026 Sep
Container
The Lancet. Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-26-00339-6,
  title = {Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.},
  author = {Dixon-Douglas JR and Drubay D and Salgado R and Acs B and van der Laak J and Yuan Y and Amgad M and Cooper L and Hagos Y and AbdulJabbar K and Meakin J and van Ginneken B and Yan H and Lemonnier J and Penault-Llorca F and Lacroix-Triki M and Joensuu H and Kellokumpu-Lehtinen PL and Loibl S and Denkert C and Viale G and Colleoni MA and Sotiriou C and Piccart M and Dieci MV and Demaria S and Kammler R and Wolff AC and Sparano JA and Adams S and Badve S and Gray RJ and Curigliano G and Salomon AV and Nielsen TO and Pusztai L and Ciompi F and Michiels S and Loi S and International Immuno-Oncology Biomarker Working Group},
  year = {2026},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(26)00339-6},
  url = {https://doi.org/10.1016/s1470-2045(26)00339-6}
}

RIS

TY  - JOUR
TI  - Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
AU  - Dixon-Douglas JR
AU  - Drubay D
AU  - Salgado R
AU  - Acs B
AU  - van der Laak J
AU  - Yuan Y
AU  - Amgad M
AU  - Cooper L
AU  - Hagos Y
AU  - AbdulJabbar K
AU  - Meakin J
AU  - van Ginneken B
AU  - Yan H
AU  - Lemonnier J
AU  - Penault-Llorca F
AU  - Lacroix-Triki M
AU  - Joensuu H
AU  - Kellokumpu-Lehtinen PL
AU  - Loibl S
AU  - Denkert C
AU  - Viale G
AU  - Colleoni MA
AU  - Sotiriou C
AU  - Piccart M
AU  - Dieci MV
AU  - Demaria S
AU  - Kammler R
AU  - Wolff AC
AU  - Sparano JA
AU  - Adams S
AU  - Badve S
AU  - Gray RJ
AU  - Curigliano G
AU  - Salomon AV
AU  - Nielsen TO
AU  - Pusztai L
AU  - Ciompi F
AU  - Michiels S
AU  - Loi S
AU  - International Immuno-Oncology Biomarker Working Group
PY  - 2026
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(26)00339-6
UR  - https://doi.org/10.1016/s1470-2045(26)00339-6
ER  - 

APA

JR, D., D, D., R, S., B, A., J, V. D. L., Y, Y., M, A., L, C., Y, H., K, A., J, M., B, V. G., H, Y., J, L., F, P., M, L., H, J., PL, K., S, L., C, D., G, V., MA, C., C, S., M, P., MV, D., S, D., R, K., AC, W., JA, S., S, A., S, B., RJ, G., G, C., AV, S., TO, N., L, P., F, C., S, M., S, L., & Group, I. I. B. W. (2026). Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(26)00339-6

Source records